Integra Lifesciences Holdings IART Cash Flow Statement (2009-2026)

NASDAQ IART
$14.53 +0.16 (+1.11%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Integra Lifesciences Holdings Quarterly Cash Flow Statement

Periods 70 quarters
Latest Sep 2026

Integra Lifesciences Holdings reported cash from operations of $95.98M and free cash flow of $85.73M for the quarter ended Sep 2026, up 134.6% year over year. This cash flow statement covers 70 quarters of results from Jun 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
45.38M32.90M44.79M49.92M52.95M24.23M4.18M19.50M19.83M-3.28M-12.40M-10.70M19.44M-25.29M-484.07M-5.40M-1.70M-4.62M4.48M14.85M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.72M1.72M1.67M1.75M1.70M1.89M1.42M1.42M1.43M1.40M1.46M1.34M1.40M1.39M1.89M1.32M1.02M1.00M1.02M1.07M
Depreciation & Amortization (CF)Dep. & Amort.
30.75M29.72M29.61M29.47M29.50M31.14M30.83M30.56M30.99M30.57M36.78M35.96M37.59M37.19M37.69M38.52M38.43M38.43M38.14M39.06M
Share-based CompensationStock Comp.
6.43M6.29M6.74M8.97M5.73M3.62M5.27M5.46M5.79M5.60M7.24M4.38M7.15M1.87M5.30M5.58M5.84M5.17M5.84M2.90M
Deferred Taxes
10.74M3.54M4.00M-6.10M-6.02M1.95M-0.23M1.24M-14.85M-2.86M-1.84M-9.04M-6.99M-1.83M-44.83M-8.65M-10.95M1.33M-4.33M0.70M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
-0.17M-0.71M0.64M1.56M0.02M0.08M0.00M-0.01M-1.25M-0.07M1.34M-0.50M0.00M0.00M-0.09M-0.64M-1.48M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
7.06M5.08M0.03M0.04M511.37M
Other non-cash itemsOther Non-Cash
-0.88M-0.78M-3.62M-12.04M-1.05M5.96M1.87M2.57M4.68M0.61M1.90M-2.95M-4.51M-0.42M-0.39M-14.75M-6.77M-0.96M3.14M-1.27M
Change in Working Capital
Change in ReceivablesChange Receivables
10.17M3.12M6.52M14.24M10.04M-10.04M5.22M-0.22M0.46M-16.83M6.72M-28.75M31.46M-21.45M27.99M-22.51M16.45M-13.65M3.04M-17.96M
Change in InventoryChange Inventory
-8.97M11.56M6.02M6.87M4.68M25.42M2.13M15.80M16.42M19.02M-1.74M10.30M0.57M13.70M6.38M23.35M3.34M4.33M-0.47M-24.13M
Change in Accrued ExpensesChange Accrued Exp.
-0.98M-9.75M-4.80M13.75M18.15M-4.98M-10.92M-6.24M1.91M-19.21M15.07M6.83M-5.36M-18.00M15.92M5.78M23.02M-19.19M-15.20M-4.15M
Change in Other Operating AssetsOther Assets Change
7.47M2.76M-5.38M-8.59M4.77M8.17M10.52M11.78M-24.59M2.34M4.92M28.89M-25.12M16.04M2.84M-17.22M-2.20M20.49M8.44M-0.50M
Change in Other Operating LiabilitiesOther Liabilities Change
-15.59M-2.58M-4.77M-4.42M11.60M-14.07M13.79M-0.47M0.47M0.39M-4.24M7.01M0.29M1.63M3.26M2.13M-20.78M-0.26M0.07M-1.26M
Other Working Capital ChangesOther WC Changes
-23.06M-5.34M0.61M4.17M6.83M-22.25M3.27M-12.25M25.06M-1.95M-9.16M-21.88M25.41M-14.41M0.42M19.35M-18.58M-20.75M-8.36M-0.76M
Other Operating Activities (as filed)
Cash from OperationsCash from Ops.
69.28M44.34M66.48M68.31M85.33M26.16M28.28M26.77M58.75M15.76M40.40M22.49M50.74M-11.26M8.92M40.91M11.82M9.80M22.80M95.98M
Investing Activities
Capital ExpendituresCapex
27.43M9.33M9.41M9.16M14.46M13.70M15.55M13.08M24.54M15.47M29.71M29.65M29.60M28.92M20.15M15.16M17.21M14.85M12.31M10.25M
Sales of Property, Plant and EquipmentPP&E (Sale)
11.15M
Change in Property, Plant and EquipmentChange in PP&E
-27.43M-9.33M-9.41M-9.16M-3.31M-13.70M-15.55M-13.08M-24.54M-15.47M-29.71M-29.65M-29.60M-28.92M-20.15M-15.16M-17.21M-14.85M-12.31M-10.25M
Change in IntangiblesChange Intangibless
4.74M-4.74M
Acquisitions
51.51M-4.18M
Divestments
23.96M
Net of Acquisitions & DivestmentsNet Acquisitions
23.96M-51.51M4.18M
Purchase of InvestmentsInvestments Purchased
32.69M38.50M10.50M7.00M1.50M30.98M
Sale and Maturity of InvestmentsInvestments Sold
35.25M7.00M
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing Activities (as filed)Other investing (as filed)
5.38M-4.13M-10.49M
Cash from Investing ActivitiesCash from Investing
-27.49M-14.07M-4.50M14.81M-54.82M-13.70M-15.55M-7.70M-57.23M-53.97M-322.20M-10.40M-4.25M-35.92M-21.65M-15.59M-34.91M-14.85M-43.28M-10.25M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
12.05M11.25M11.75M11.25M6.50M10.20M5.00M131.70M18.20M370.50M58.80M21.80M35.40M54.40M12.90M603.70M49.70M44.50M31.40M19.90M
Long-Term Debt RepaymentsLT Debt Repayment
11.25M11.75M11.25M17.75M107.80M12.40M16.70M56.80M24.70M15.10M90.54M41.54M39.94M15.24M15.89M613.67M25.09M35.59M24.89M65.99M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.80M-0.50M0.50M-6.50M-101.30M-2.20M-11.70M74.90M-6.50M355.40M-31.74M-19.74M-4.54M39.16M-2.99M-9.97M24.61M8.91M6.51M-46.09M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.80M-0.50M0.50M-6.50M-101.30M-2.20M-11.70M74.90M-6.50M355.40M-31.74M-19.74M-4.54M39.16M-2.99M-9.97M24.61M8.91M6.51M-46.09M
Change in Capital Stock
Common Stock IssuedStock Issued
0.24M1.24M0.35M3.87M2.33M1.11M0.66M0.23M6.40M0.96M0.76M
Shares Repurchased
125.00M150.00M125.00M50.00M2.47M
Net Shares Issued and RepurchasedNet Shares Issued
0.24M-123.76M0.35M3.87M-147.67M1.11M-124.35M0.23M6.40M-50.00M-2.47M0.96M0.76M
Net Equity Issued and RepurchasedNet Equity Issued
0.24M-123.76M0.35M3.87M-147.67M1.11M-124.35M0.23M6.40M-50.00M-2.47M0.96M0.76M
Other financing activities (as filed)
-0.52M-9.20M-14.00M-1.14M-0.27M-12.81M-0.10M-0.21M-0.62M-3.12M-12.00M-0.17M-0.14M-4.74M-17.93M-0.27M-0.27M-1.38M-7.33M-0.20M
Cash from Financing ActivitiesCash from Financing
0.52M-133.47M-13.15M-7.64M-97.70M-162.68M-10.69M-49.66M-6.89M358.68M-93.75M-19.92M-7.15M35.38M-21.14M-10.25M24.34M8.30M-0.82M-46.29M
Additional items
Exchange Rate EffectFX Effect
0.90M-3.17M-8.77M-10.69M11.91M0.94M-0.21M-4.87M8.04M-4.96M-1.13M7.75M-8.12M4.53M12.68M-0.80M1.61M-1.49M-1.10M-1.60M
Change in Cash
43.22M-106.36M40.06M64.79M-55.28M-149.29M1.83M-35.46M2.67M315.50M-376.67M-0.08M31.22M-7.27M-21.19M14.27M2.86M1.76M-22.39M37.85M
Ending Cash Balance
513.45M407.09M447.15M511.94M456.66M307.37M309.19M273.73M276.40M591.91M215.24M215.16M246.38M239.10M217.91M232.19M235.05M236.81M214.42M252.26M
Free Cash FlowFCF
41.85M35.02M57.07M59.16M70.88M12.45M12.73M13.69M34.22M0.29M10.69M-7.16M21.14M-40.18M-11.23M25.75M-5.40M-5.05M10.50M85.73M
Net Cash FlowNCF
42.31M-103.19M48.83M75.48M-67.19M-150.23M2.04M-30.59M-5.37M320.47M-375.55M-7.83M39.34M-11.80M-33.87M15.07M1.25M3.25M-21.30M39.44M

Integra Lifesciences Holdings Cash Flow Statement API

Pull Integra Lifesciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IART&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY